Inclusion Criteria:  Confirmed diagnosis of PV according to either the 2008 or 2016 WHO classification criteria PV patients being only treated with phlebotomy and the interval is 4-9 weeks  Exclusion Criteria:  Patients administrated drugs for PV treatment such as hydroxyurea or ruxolitinib (aspirin is excluded)